No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Xenazine is a drug used to treat tardive dyskinesia, a neurological disorder characterized by involuntary movements. It is a member of the musculoskeletal disorders drugs market, which includes drugs used to treat a variety of conditions such as arthritis, osteoporosis, and fibromyalgia. These drugs are used to reduce pain, improve mobility, and reduce inflammation.
Xenazine is a brand name for tetrabenazine, a drug that works by blocking dopamine receptors in the brain. It is used to reduce the severity of tardive dyskinesia symptoms, such as involuntary movements of the face, tongue, and extremities. It is available in tablet form and is taken orally.
The musculoskeletal disorders drugs market is highly competitive, with many companies offering products to treat a variety of conditions. Some of the major players in the market include Pfizer, Novartis, Merck, and Johnson & Johnson. Other companies include AbbVie, Amgen, and Bristol-Myers Squibb. Show Less Read more
